{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:52Z","timestamp":1707524572565},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,14]]},"DOI":"10.7759\/cureus.25002","type":"journal-article","created":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T04:31:01Z","timestamp":1652589061000},"source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Obesity on Hodgkin\u2019s Lymphoma Patients Treated With Uniform Chemotherapy Protocol at Princess Noorah Oncology Center, National Guard Health Affairs, Jeddah, Saudi Arabia: Retrospective Matched Cohort"],"prefix":"10.7759","author":[{"given":"Alaa  T","family":"Alsharif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Aldawsari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad M","family":"Babateen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meshaal A","family":"Kouther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal F","family":"Aljahdali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Absi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taghreed","family":"Aldosary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed E","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Kumar and Clark's Cases in Clinical Medicine","author":"Kumar P","year":"2021","unstructured":"Kumar P, Clark ML. Kumar and Clark's Cases in Clinical Medicine. Feather A, Randall D, Waterhouse M (ed): Elsevier, New York\/London; 2021."},{"key":"ref2","unstructured":"Cancer incidence report Saudi Arabia. (2016). Accessed. 7 may 2022: https:\/\/nhic.gov.sa\/eServices\/Documents\/2016.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2015.16.5.2069","article-title":"Changing trends of adult lymphoma in the Kingdom of Saudi Arabia - comparison of data sources","volume":"16","author":"Rauf MS","year":"2015","unstructured":"Rauf MS, Akhtar S, Maghfoor I. Changing trends of adult lymphoma in the Kingdom of Saudi Arabia - comparison of data sources. Asian Pac J Cancer Prev. 2015, 16:2069-72. 10.7314\/apjcp.2015.16.5.2069","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.09.085","article-title":"Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group","volume":"23","author":"Meyer RM","year":"2005","unstructured":"Meyer RM, Gospodarowicz MK, Connors JM, et al.. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. J Clin Oncol. 2005, 23:4634-42. 10.1200\/JCO.2005.09.085","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-006-0034-9","article-title":"Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatment","volume":"14","author":"Schwenkglenks M","year":"2006","unstructured":"Schwenkglenks M, Jackisch C, Constenla M, et al.. Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatment. Support Care Cancer. 2006, 14:901-9. 10.1007\/s00520-006-0034-9","journal-title":"Support Care Cancer"},{"key":"ref6","unstructured":"Obesity Control Program. (2015). Accessed. Accessed: 17 nov. 2018: https:\/\/www.moh.gov.sa\/en\/OCP\/Pages\/DirectorMessage.aspx."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwh041","article-title":"Association of obesity and cancer risk in Canada","volume":"159","author":"Pan SY","year":"2004","unstructured":"Pan SY, Johnson KC, Ugnat AM, Wen SW, Mao Y. Association of obesity and cancer risk in Canada. Am J Epidemiol. 2004, 159:259-68. 10.1093\/aje\/kwh041","journal-title":"Am J Epidemiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.01.027","article-title":"Pretreatment body mass index as an independent prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy: findings from a randomised trial","volume":"49","author":"Huang PY","year":"2013","unstructured":"Huang PY, Wang CT, Cao KJ, et al.. Pretreatment body mass index as an independent prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy: findings from a randomised trial. Eur J Cancer. 2013, 49:1923-31. 10.1016\/j.ejca.2013.01.027","journal-title":"Eur J Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi145","article-title":"Risk profile and outcome in Hodgkin's lymphoma: is obesity beneficial?","volume":"16","author":"Landgren O","year":"2005","unstructured":"Landgren O, Andr\u00e9n H, Nilsson B, Ekbom A, Bj\u00f6rkholm M. Risk profile and outcome in Hodgkin's lymphoma: is obesity beneficial?. Ann Oncol. 2005, 16:838-40. 10.1093\/annonc\/mdi145","journal-title":"Ann Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2438_31","article-title":"Outcomes of treatment for obese patients with advanced Hodgkin lymphoma in the RATHL trial [Poster]","volume":"35","author":"Preston A","year":"2017","unstructured":"Preston A, Kirkwood A, Federico M, et al.. Outcomes of treatment for obese patients with advanced Hodgkin lymphoma in the RATHL trial [Poster]. Hematological Oncology. 2017, 35:172. 10.1002\/hon.2438_31","journal-title":"Hematological Oncology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-17-0338","article-title":"Adipocytes sequester and metabolize the chemotherapeutic daunorubicin","volume":"15","author":"Sheng X","year":"2017","unstructured":"Sheng X, Parmentier JH, Tucci J, et al.. Adipocytes sequester and metabolize the chemotherapeutic daunorubicin. Mol Cancer Res. 2017, 15:1704-13. 10.1158\/1541-7786.MCR-17-0338","journal-title":"Mol Cancer Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/291546","article-title":"Obesity as a major risk factor for cancer","volume":"2013","author":"De Pergola G","year":"2013","unstructured":"De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes. 2013, 2013:291546. 10.1155\/2013\/291546","journal-title":"J Obes"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-006-0042-6","article-title":"Obesity and the risk of Hodgkin lymphoma (United Kingdom)","volume":"17","author":"Willett EV","year":"2006","unstructured":"Willett EV, Roman E. Obesity and the risk of Hodgkin lymphoma (United Kingdom). Cancer Causes Control. 2006, 17:1103-6. 10.1007\/s10552-006-0042-6","journal-title":"Cancer Causes Control"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14702","article-title":"Physical activity, obesity and survival in diffuse large B-cell and follicular lymphoma cases","volume":"178","author":"Boyle T","year":"2017","unstructured":"Boyle T, Connors JM, Gascoyne RD, Berry BR, Sehn LH, Bashash M, Spinelli JJ. Physical activity, obesity and survival in diffuse large B-cell and follicular lymphoma cases. Br J Haematol. 2017, 178:442-7. 10.1111\/bjh.14702","journal-title":"Br J Haematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0206","article-title":"Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma","volume":"15","author":"Lichtman MA","year":"2010","unstructured":"Lichtman MA. Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma. Oncologist. 2010, 15:1083-101. 10.1634\/theoncologist.2010-0206","journal-title":"Oncologist"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.4051","article-title":"American Society of Clinical Oncology obesity initiative: rationale, progress, and future directions","volume":"34","author":"Ligibel JA","year":"2016","unstructured":"Ligibel JA, Wollins D. American Society of Clinical Oncology obesity initiative: rationale, progress, and future directions. J Clin Oncol. 2016, 34:4256-60. 10.1200\/JCO.2016.67.4051","journal-title":"J Clin Oncol"},{"key":"ref17","unstructured":"NCI Dictionary of Cancer Terms. (2022). Accessed. May 7, 2022: https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/remission."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5402\/2013\/680536","article-title":"The association between obesity and cancer risk: a meta-analysis of observational studies from 1985 to 2011","volume":"2013","author":"Dobbins M","year":"2013","unstructured":"Dobbins M, Decorby K, Choi BC. The association between obesity and cancer risk: a meta-analysis of observational studies from 1985 to 2011. ISRN Prev Med. 2013, 2013:680536. 10.5402\/2013\/680536","journal-title":"ISRN Prev Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0401-1","article-title":"Body mass index and Hodgkin's lymphoma: UK population-based cohort study of 5.8 million individuals","volume":"120","author":"Strongman H","year":"2019","unstructured":"Strongman H, Brown A, Smeeth L, Bhaskaran K. Body mass index and Hodgkin's lymphoma: UK population-based cohort study of 5.8 million individuals. Br J Cancer. 2019, 120:768-70. 10.1038\/s41416-019-0401-1","journal-title":"Br J Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24955","article-title":"Association between obesity and the risk of malignant lymphoma in Japanese: a case-control study","volume":"126","author":"Kanda J","year":"2010","unstructured":"Kanda J, Matsuo K, Suzuki T, et al.. Association between obesity and the risk of malignant lymphoma in Japanese: a case-control study. Int J Cancer. 2010, 126:2416-25. 10.1002\/ijc.24955","journal-title":"Int J Cancer"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt294","article-title":"Toxic effect of chemotherapy dosing using actual body weight in obese versus normal-weight patients: a systematic review and meta-analysis","volume":"24","author":"Hourdequin KC","year":"2013","unstructured":"Hourdequin KC, Schpero WL, McKenna DR, Piazik BL, Larson RJ. Toxic effect of chemotherapy dosing using actual body weight in obese versus normal-weight patients: a systematic review and meta-analysis. Ann Oncol. 2013, 24:2952-62. 10.1093\/annonc\/mdt294","journal-title":"Ann Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/95351-the-impact-of-obesity-on-hodgkins-lymphoma-patients-treated-with-uniform-chemotherapy-protocol-at-princess-noorah-oncology-center-national-guard-health-affairs-jeddah-saudi-arabia-retrospective-matched-cohort","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:17Z","timestamp":1707507617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/95351-the-impact-of-obesity-on-hodgkins-lymphoma-patients-treated-with-uniform-chemotherapy-protocol-at-princess-noorah-oncology-center-national-guard-health-affairs-jeddah-saudi-arabia-retrospective-matched-cohort"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,14]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.25002","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,14]]}}}